Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin

American Journal of Hematology

Volumn 89, Issue 5, 2014, Pages 524-529

  Evstatiev, Rayko ^a   Bukaty, Adam ^a   Jimenez, Kristine ^a   Kulnigg Dabsch, Stefanie ^a   Surman, Lidia ^a   Schmid, Werner ^a   Eferl, Robert ^a,b   Lippert, Kathrin ^a   Scheiber Mojdehkar, Barbara ^a   Michael Kvasnicka, Hans ^c   Khare, Vineeta ^a   Gasche, Christoph ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOPOIETIC GROWTH FACTOR; HEPCIDIN; INTERLEUKIN 11; INTERLEUKIN 6; MESSENGER RNA; THROMBOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; BONE MARROW; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL SIZE; CHRONIC DISEASE; CONTROLLED STUDY; IRON DEFICIENCY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEGAKARYOBLAST; MEGAKARYOPOIESIS; NONHUMAN; PHENOTYPE; PLOIDY; PRIORITY JOURNAL; RAT; STEM CELL; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOCYTE VOLUME; THROMBOCYTOSIS;

ANIMALS; BLOOD PLATELETS; IRON; MALE; MEGAKARYOCYTES; MYELOPOIESIS; PHENOTYPE; PLATELET AGGREGATION; PLATELET COUNT; RATS; RATS, SPRAGUE-DAWLEY; THROMBOPOIETIN;

EID: 84898462696     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23682     Document Type: Article

References (36)

1. Dan K. Thrombocytosis in iron deficiency anemia. Intern Med 2005;44:1025-1026.
2. Voudoukis E, Karmiris K, Oustamanolakis P, et al. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2013;25:1212-1216.
3. Kulnigg-Dabsch S, Evstatiev R, Dejaco C, et al. Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia. PloS One 2012;7:e34520.
4. Kulnigg-Dabsch S, Schmid W, Howaldt S, et al. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: The randomized, controlled thromboVIT trial. Inflammatory Bowel Dis 2013;19:1609-1616.
5. Choi SI, Simone JV. Platelet production in experimental iron deficiency anemia. Blood 1973;42:219-228.
6. Choi SI, Simone JV, Jackson CW. Megakaryocytopoiesis in experimental iron deficiency anemia. Blood 1974;43:111-120.
7. Keung YK, Owen J. Iron deficiency and thrombosis: Literature review. Clin Appl Thromb Hemost 2004;10:387-391.
8. Simanek R, Vormittag R, Ay C, et al. High platelet count associated with venous thromboembolism in cancer patients: Results from the Vienna Cancer and Thrombosis Study (CATS). J Thromb Haemost 2010;8:114-120.
9. Khorana AA, Francis CW, Culakova E, et al. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. Cancer 2005;104:2822-2829.
10. Khorana AA, Kuderer NM, Culakova E, et al. Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood 2008;111:4902-4907.
11. Geddis AE, Fox N, Tkacenko E, et al. Endomitotic megakaryocytes that form a bipolar spindle exhibit cleavage furrow ingression followed by furrow regression. Cell Cycle 2007;6:455-460.
12. Lordier L, Jalil A, Aurade F, et al. Megakaryocyte endomitosis is a failure of late cytokinesis related to defects in the contractile ring and Rho/Rock signaling. Blood 2008;112:3164-3174.
13. Lordier L, Pan J, Naim V, et al. Presence of a defect in karyokinesis during megakaryocyte endomitosis. Cell Cycle 2012;11:4385-4389.
14. Kaushansky K. Historical review: Megakaryopoiesis and thrombopoiesis. Blood 2008;111:981-986.
15. Levine RF, Fedorko ME. Isolation of intact megakaryocytes from guinea pig femoral marrow. Successful harvest made possible with inhibitions of platelet aggregation; enrichment achieved with a two-step separation technique. J Cell Biol 1976;69:159-172.
16. Jackson CW. Cholinesterase as a possible marker for early cells of the megakaryocytic series. Blood 1973;42:413-421.
17. Cook CI, Yu BP. Iron accumulation in aging: Modulation by dietary restriction. Mech Ageing Dev 1998;102:1-13.
18. Wolford ST, Schroer RA, Gallo PP, et al. Age-related changes in serum chemistry and hematology values in normal Sprague-Dawley rats. Fundam Appl Toxicol 1987;8:80-88.
19. Schwertz H, Koster S, Kahr WH, et al. Anucleate platelets generate progeny. Blood 2010;115:3801-3809.
20. Evstatiev R, Gasche C. Iron sensing and signalling. Gut 2012;61:933-952.
21. Ravid K, Lu J, Zimmet JM, et al. Roads to polyploidy: The megakaryocyte example. J Cell Physiol 2002;190:7-20.
22. Raslova H, Kauffmann A, Sekkai D, et al. Interrelation between polyploidization and megakaryocyte differentiation: A gene profiling approach. Blood 2007;109:3225-3234.
23. Mattia G, Vulcano F, Milazzo L, et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 2002;99:888-897.
24. Akan H, Guven N, Aydogdu I, et al. Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis. Acta Haematol 2000;103:152-156.
25. Beguin Y, Loo M, R'Zik S, et al. Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: Correlation of platelet count with erythropoietic activity and iron parameters. Eur J Haematol 1994;53:265-270.
26. Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995;85:1719-1726.
27. Racke FK. EPO and TPO sequences do not explain thrombocytosis in iron deficiency anemia. J Pediatr Hematol Oncol 2003;25:919.
28. Klimchenko O, Mori M, Distefano A, et al. A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. Blood 2009;114:1506-1517.
29. Geddis AE, Kaushansky K. Cross-reactivity between erythropoietin and thrombopoietin at the level of Mpl does not account for the thrombocytosis seen in iron deficiency. J Pediatr Hematol Oncol 2003;25:919-920.
30. Dahl NV, Henry DH, Coyne DW. Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role? Semin Dial 2008;21:210-211.
31. Streja E, Kovesdy CP, Greenland S, et al. Erythropoietin, iron depletion, and relative thrombocytosis: A possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis 2008;52:727-736.
32. Loo M, Beguin Y. The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood 1999;93:3286-3293.
33. Danese S, Papa A, Saibeni S, et al. Inflammation and coagulation in inflammatory bowel disease: The clot thickens. Am J Gastroenterol 2007;102:174-186.
34. Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume: A link between thrombosis and inflammation? Curr Pharm Des 2011;17:47-58.
35. Cho SY, Yang JJ, Suh JT, et al. Mean platelet volume/platelet count ratio in anemia. Platelets 2013;24:244-245.
36. Toprak SK, Erismis B, Karakus S, et al. Does thrombocyte size give us an idea about thrombocytosis etiology? Scientific World J 2012;2012:598653.